CIK 0001422142 · Non-accelerated filer<br>Smaller reporting company
Whitehawk Therapeutics, Inc.
Sign in to watch- Ticker
- WHWK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547850
- Phone
- 551-321-2234
- Business address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | BALL BRYAN See remarks | Sale | −1,834 | $3.31 | $6K | 206,019 |
| 2026-03-02 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Sale | −2,594 | $3.31 | $9K | 28,100 |
| 2026-03-01 | Lennon David James CHIEF EXECUTIVE OFFICER | Option exercise | +16,250 | 49,679 | ||
| 2026-03-01 | Lennon David James CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −16,250 | 32,500 | ||
| 2026-03-01 | BALL BRYAN See remarks | Option exercise | +5,000 | 207,853 | ||
| 2026-03-01 | BALL BRYAN See remarks | Option exercise · Restricted Stock Units | −5,000 | 10,000 | ||
| 2026-03-01 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Option exercise | +6,750 | 30,694 | ||
| 2026-03-01 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −6,750 | 13,500 | ||
| 2025-12-01 | Dugan Margaret Chief Medical Officer | Grant or award · Stock option (right to buy) | +650,000 | 650,000 | ||
| 2025-12-01 | Dugan Margaret Chief Medical Officer | Grant or award · Restricted Stock Units | +55,309 | 55,309 | ||
| 2025-06-17 | Zhao Baiteng Director | Grant or award · Stock Option (right to buy) | +40,006 | 40,006 | ||
| 2025-06-12 | Desai Neil Director | Grant or award · Stock Option (right to buy) | +40,006 | 40,006 | ||
| 2025-06-12 | Hirmand Mohammad Director | Grant or award · Stock Option (right to buy) | +40,006 | 40,006 | ||
| 2025-06-12 | Maroun Richard E Director | Grant or award · Stock Option (right to buy) | +40,006 | 40,006 | ||
| 2025-06-12 | Reeve Emma Director | Grant or award · Stock Option (right to buy) | +40,006 | 40,006 | ||
| 2025-06-12 | Castelein Caley Director | Grant or award · Stock Option (right to buy) | +40,006 | 40,006 | ||
| 2025-06-12 | Dalal Anupam Director | Grant or award · Stock Option (right to buy) | +40,006 | 40,006 | ||
| 2025-06-12 | Aghazadeh Behzad Director | Grant or award · Stock Option (right to buy) | +40,006 | 40,006 | ||
| 2025-04-01 | BALL BRYAN See remarks | Grant or award · Stock Option (right to buy) | +366,532 | 366,532 | ||
| 2025-04-01 | BALL BRYAN See remarks | Grant or award · Restricted Stock Units | +366,532 | 366,532 |
Page 4 of 9 · 171 trades